drugset / Trial / NCT06618534
Azithromycin for Meningococcal Carriage
Phase 2
Completed
764 enrolled
Emory University
Centers for Disease Control and Prevention · collabGeorgia Department of Public Health · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effectiveness of azithromycin in the eradication of nasopharyngeal carriage of N. meningitidis
Timeline
- Start
- 2024-11-12
- Primary completion
- 2026-04-29
- Completion
- 2026-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 500 mg | Oral |